Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'hypolipidemic drugs' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 111 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Elholm, M; Hollas, H; Issalene, C; Barroso, JFV; Berge, RK; Flatmark, T
      Transient up-regulation of liver mitochondrial thymidine kinase activity in proliferating mitochondria

      IUBMB LIFE
    2. Dzhekova-Stojkova, S; Bogdanska, J; Stojkova, Z
      Peroxisome proliferators: Their biological and toxicological effects

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    3. Bonilla, S; Redonnet, A; Noel-Suberville, C; Groubet, R; Pallet, V; Higueret, P
      Effect of a pharmacological activation of PPAR on the expression of RAR and TR in rat liver

      JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
    4. Bonilla, S; Redonnet, A; Noel-Suberville, C; Groubet, R; Pallet, V; Higueret, P
      Effect of a pharmacological activation of PPAR on the expression of RAR and TR in rat liver

      JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
    5. Palut, D; Ludwicki, JK; Kostka, G; Kopec-Szlezak, J; Wiadrowska, B; Lembowicz, K
      Studies of early hepatocellular proliferation and peroxisomal proliferation in Wistar rats treated with herbicide diclofop

      TOXICOLOGY
    6. Melnick, RL
      Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?

      ENVIRONMENTAL HEALTH PERSPECTIVES
    7. Oliver, WR; Shenk, JL; Snaith, MR; Russell, CS; Plunket, KD; Bodkin, NL; Lewis, MC; Winegar, DA; Sznaidman, ML; Lambert, MH; Xu, HE; Sternbach, DD; Kliewer, SA; Hansen, BC; Willson, TM
      A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    8. Winegar, DA; Brown, PJ; Wilkison, WO; Lewis, MC; Ott, RJ; Tong, WQ; Brown, HR; Lehmann, JM; Kliewer, SA; Plunket, KD; Way, JM; Bodkin, NL; Hansen, BC
      Effects of fenofibrate on lipid parameters in obese rhesus monkeys

      JOURNAL OF LIPID RESEARCH
    9. Young, ME; Laws, FA; Goodwin, GW; Taegtmeyer, H
      Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart

      JOURNAL OF BIOLOGICAL CHEMISTRY
    10. Elholm, R; Dam, I; Jorgensen, C; Krogsdam, AM; Holst, D; Kratchmarova, I; Gottlicher, M; Gustafsson, JA; Berge, R; Flatmark, T; Knudsen, J; Mandrup, S; Kristiansen, K
      Acyl-CoA esters antagonize the effects of ligands on peroxisome proliferator-activated receptor alpha conformation, DNA binding, and interaction withco-factors

      JOURNAL OF BIOLOGICAL CHEMISTRY
    11. Hertz, R; Sheena, V; Kalderon, B; Berman, I; Bar-Tana, J
      Suppression of hepatocyte nuclear factor-4 alpha by acyl-CoA thioesters ofhypolipidemic peroxisome proliferators

      BIOCHEMICAL PHARMACOLOGY
    12. Collett, GP; Betts, AM; Johnson, MI; Pulimood, AB; Cook, S; Neal, DE; Robson, CN
      Peroxisome proliferator-activated receptor alpha is an androgen-responsivegene in human prostate and is highly expressed in prostatic adenocarcinoma

      CLINICAL CANCER RESEARCH
    13. Chinetti, G; Fruchart, JC; Staels, B
      Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation

      INFLAMMATION RESEARCH
    14. Kawano, H; Nishi, F; Kamitani, Y; Ochi, H; Miyake, M; Mayumi, T; Hama, T
      Different recognition by peroxisome proliferator structures in rat peroxisomal induction: Application of sandwich ELISA using monoclonal antibody against rat peroxisomes

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    15. Ceska, R; Vrablik, M; Horinek, A
      Familial defective apolipoprotein B-100: a lesson from homozygous and heterozygous patients

      PHYSIOLOGICAL RESEARCH
    16. Everett, L; Galli, A; Crabb, D
      The role of hepatic peroxisome proliferator-activated receptors (PPARs) inhealth and disease

      LIVER
    17. Marrapodi, M; Chiang, JYL
      Peroxisome proliferator-activated receptor alpha (PPAR alpha) and agonist inhibit cholesterol 7 alpha-hydroxylase gene (CYP7A1) transcription

      JOURNAL OF LIPID RESEARCH
    18. Cheema, SK; Agellon, LB
      The murine and human cholesterol 7 alpha-hydroxylase gene promoters are differentially responsive to regulation by fatty acids mediated via peroxisome proliferator-activated receptor alpha

      JOURNAL OF BIOLOGICAL CHEMISTRY
    19. Delerive, P; Furman, C; Teissier, E; Fruchart, JC; Duriez, P; Staels, B
      Oxidized phospholipids activate PPAR alpha in a phospholipase A2-dependentmanner

      FEBS LETTERS
    20. Sakamoto, J; Kimura, H; Moriyama, S; Odaka, H; Momose, Y; Sugiyama, Y; Sawada, H
      Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    21. Squire, TL; Andrews, MT
      Genetic control of carbon utilization during hibernation: Mechanistic considerations

      LIFE IN THE COLD
    22. Andersson, Y; Majd, Z; Lefebvre, AM; Martin, G; Sechkin, AV; Kosykh, V; Fruchart, JC; Najib, J; Staels, B
      Developmental and pharmacological regulation of apolipoprotein C-II gene expression - Comparison with apo C-I and apo C-III gene regulation

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    23. Rao, MS; Subbarao, V
      Inhibition of ciprofibrate-induced hepatocarcinogenesis in the rat by dimethylthiourea, a scavenger of hydroxyl radical

      ONCOLOGY REPORTS
    24. Holden, PR; Tugwood, JD
      Peroxisome proliferator-activated receptor alpha: Role in rodent liver cancer and species differences

      JOURNAL OF MOLECULAR ENDOCRINOLOGY
    25. Edvardsson, U; Alexandersson, M; von Lowenhielm, HB; Nystrom, AC; Ljung, B; Nilsson, F; Dahllof, B
      A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643

      ELECTROPHORESIS
    26. Hasmall, SC; Roberts, RA
      The perturbation of apoptosis and mitosis by drugs and xenobiotics

      PHARMACOLOGY & THERAPEUTICS
    27. Eagon, PK; Teepe, AG; Elm, MS; Tadic, SD; Epley, MJ; Beiler, BE; Shinozuka, H; Rao, KN
      Hepatic hyperplasia and cancer in rats: alterations in copper metabolism

      CARCINOGENESIS
    28. Shabalina, IG; Panaretakis, T; Bergstrand, A; DePierre, JW
      Effects of the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid, on apoptosis in human hepatoma HepG2 cells

      CARCINOGENESIS
    29. Edvardsson, U; Bergstrom, M; Alexandersson, M; Bamberg, K; Ljung, B; Dahllof, B
      Rosiglitazone (BRL49653), a PPAR gamma-selective agonist, causes peroxisome proliferator-like liver effects in obese mice

      JOURNAL OF LIPID RESEARCH
    30. Raspe, E; Madsen, L; Lefebvre, AM; Leitersdorf, I; Gelman, L; Peinado-Onsurbe, J; Dallongeville, J; Fruchart, JC; Berge, R; Staels, B
      Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPAR alpha activation

      JOURNAL OF LIPID RESEARCH
    31. Hill, MR; Clarke, S; Rodgers, K; Thornhill, B; Peters, JM; Gonzalez, FJ; Gimble, JM
      Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia

      INFECTION AND IMMUNITY
    32. Pretti, C; Novi, S; Longo, V; Gervasi, PG
      Effect of clofibrate, a peroxisome proliferator, in sea bass (Dicentrarchus labrax), a marine fish

      ENVIRONMENTAL RESEARCH
    33. Hennuyer, N; Poulain, P; Madsen, L; Berge, RK; Houdebine, LM; Branellec, D; Fruchart, JC; Fievet, C; Duverger, N; Staels, B
      Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response

      CIRCULATION
    34. Macdonald, N; Holden, PR; Roberts, RA
      Addition of peroxisome proliferator-activated receptor alpha to guinea pighepatocytes confers increased responsiveness to peroxisome proliferators

      CANCER RESEARCH
    35. Becuwe, P; Bianchi, A; Keller, JM; Dauca, M
      Effects of the peroxisome proliferator clofibric acid on superoxide dismutase expression in the human HepG2 hepatoma cell line

      BIOCHEMICAL PHARMACOLOGY
    36. YANG Q; DEPIERRE JW
      RAPID ONE-STEP ISOLATION OF MOUSE-LIVER CATALASE BY IMMOBILIZED METAL-ION AFFINITY-CHROMATOGRAPHY

      Protein expression and purification
    37. Hertz, R; Bar-Tana, J
      Peroxisome proliferator-activated receptor (PPAR) alpha activation and itsconsequences in humans

      TOXICOLOGY LETTERS
    38. James, NH; Gill, JH; Brindle, R; Woodyatt, NJ; Macdonald, N; Rolfe, M; Hasmall, SC; Tugwood, JD; Holden, PR; Roberts, RA
      Peroxisome proliferator-activated receptor (PPAR) alpha-regulated growth responses and their importance to hepatocarcinogenesis

      TOXICOLOGY LETTERS
    39. Hasmall, SC; James, NH; Soames, AR; Roberts, RA
      The peroxisome proliferator nafenopin does lot suppress hepatocyte apoptosis in guinea-pig liver in vivo nor in human hepatocytes in vitro

      ARCHIVES OF TOXICOLOGY
    40. Chazov, EI
      History of atherosclerosis study: true facts, hypotheses, speculations

      TERAPEVTICHESKII ARKHIV
    41. CORTON JC; FAN LQ; BROWN S; ANDERSON SP; BOCOS C; CATTLEY RC; MODE A; GUSTAFSSON JA
      DOWN-REGULATION OF CYTOCHROME-P450 2C FAMILY MEMBERS AND POSITIVE ACUTE-PHASE RESPONSE GENE-EXPRESSION BY PEROXISOME PROLIFERATOR CHEMICALS

      Molecular pharmacology
    42. KROETZ DL; YOOK P; COSTET P; BIANCHI P; PINEAU T
      PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA CONTROLS THE HEPATICCYP4A INDUCTION ADAPTIVE RESPONSE TO STARVATION AND DIABETES

      The Journal of biological chemistry
    43. AVIRAM M; ROSENBLAT M; BISGAIER CL; NEWTON RS
      ATORVASTATIN AND GEMFIBROZIL METABOLITES, BUT NOT THE PARENT DRUGS, ARE POTENT ANTIOXIDANTS AGAINST LIPOPROTEIN OXIDATION

      Atherosclerosis (Amsterdam)
    44. VANDENMUNCKHOF RJM; BOSCH KS; FREDERIKS WM
      THE DIFFERENT EFFECTS OF THE PEROXISOME PROLIFERATORS CLOFIBRIC ACID AND BIS(2-ETHYLHEXYL)PHTHALATE ON THE ACTIVITIES OF PEROXISOMAL OXIDASES IN RAT-LIVER

      Histochemical Journal
    45. CAJARAVILLE MP; ORBEA A; MARIGOMEZ I; CANCIO I
      PEROXISOME PROLIFERATION IN THE DIGESTIVE EPITHELIUM OF MUSSELS EXPOSED TO THE WATER ACCOMMODATED FRACTION OF 3 OILS

      Comparative biochemistry and physiology. Part C, Pharmacology toxicology & endocrinology
    46. LEFEBVRE AM; PEINADOONSURBE J; LEITERSDORF I; BRIGGS MR; PATERNITI JR; FRUCHART JC; FIEVET C; AUWERX J; STAELS B
      REGULATION OF LIPOPROTEIN METABOLISM BY THIAZOLIDINEDIONES OCCURS THROUGH A DISTINCT BUT COMPLEMENTARY MECHANISM RELATIVE TO FIBRATES

      Arteriosclerosis, thrombosis, and vascular biology
    47. FAGER G; WIKLUND O
      CHOLESTEROL REDUCTION AND CLINICAL BENEFIT - ARE THERE LIMITS TO OUR EXPECTATIONS

      Arteriosclerosis, thrombosis, and vascular biology
    48. SCHNEIDER P; KOROLENKO TA; BUSCH U
      A REVIEW OF DRUG-INDUCED LYSOSOMAL DISORDERS OF THE LIVER IN MAN AND LABORATORY-ANIMALS

      Microscopy research and technique
    49. BAUMGART E; SCHAD A; VOLKL A; FAHIMI HD
      DETECTION OF MESSENGER-RNAS ENCODING PEROXISOMAL PROTEINS BY NONRADIOACTIVE IN-SITU HYBRIDIZATION WITH DIGOXIGENIN-LABELED CRNAS

      HISTOCHEMISTRY AND CELL BIOLOGY
    50. ROSE ML; GERMOLEC D; ARTEEL GE; SCHOONHOVEN R; THURMAN RG
      DIETARY GLYCINE PREVENTS INCREASES IN HEPATOCYTE PROLIFERATION CAUSEDBY THE PEROXISOME PROLIFERATOR WY-14,643

      Chemical research in toxicology
    51. HUBER WW; GRASLKRAUPP B; STEKEL H; GSCHWENTNER C; LANG H; SCHULTEHERMANN R
      INHIBITION INSTEAD OF ENHANCEMENT OF LIPID-PEROXIDATION BY PRETREATMENT WITH THE CARCINOGENIC PEROXISOME PROLIFERATOR NAFENOPIN IN RAT-LIVER EXPOSED TO A HIGH SINGLE-DOSE OF CORN-OIL

      Archives of toxicology
    52. VOSKOBOINIK I; OOI SG; DREW R; AHOKAS JT
      PEROXISOME PROLIFERATORS INCREASE THE FORMATION OF BPDE-DNA ADDUCTS IN ISOLATED RAT HEPATOCYTES

      Toxicology
    53. DUCLOS S; BRIDE J; RAMIREZ LC; BOURNOT P
      PEROXISOME PROLIFERATION AND BETA-OXIDATION IN FAO AND MH(1)C(1) RAT HEPATOMA-CELLS, HEPG2 HUMAN HEPATOBLASTOMA CELLS AND CULTURED HUMAN HEPATOCYTES - EFFECT OF CIPROFIBRATE

      European journal of cell biology
    54. HARRIS WS; DUJOVNE CA; WINDSOR SL; GERROND LLC; NEWTON FA; GELFAND RA
      INHIBITING CHOLESTEROL ABSORPTION WITH CP-88,818 (BETA-TIGOGENIN CELLOBIOSIDE TIQUESIDE) - STUDIES IN NORMAL AND HYPERLIPIDEMIC SUBJECTS

      Journal of cardiovascular pharmacology
    55. BEIER K; VOLKL A; METZGER C; MAYER D; BANNASCH P; FAHIMI HD
      HEPATIC ZONATION OF THE INDUCTION OF CYTOCHROME-P450 IVA, PEROXISOMALLIPID BETA-OXIDATION ENZYMES AND PEROXISOME PROLIFERATION IN RATS TREATED WITH DEHYDROEPIANDROSTERONE (DHEA) - EVIDENCE OF DISTINCT ZONAL AND SEX-SPECIFIC DIFFERENCES

      Carcinogenesis
    56. BOJES HK; GERMOLEC DR; SIMEONOVA P; BRUCCOLERI A; SCHOONHOVEN R; LUSTER MI; THURMAN RG
      ANTIBODIES TO TUMOR-NECROSIS-FACTOR-ALPHA PREVENT INCREASES IN CELL REPLICATION IN LIVER DUE TO THE POTENT PEROXISOME PROLIFERATOR, WY-14,643

      Carcinogenesis
    57. WANG KS; MOCK NI; MOCK DM
      BIOTIN BIOTRANSFORMATION TO BISNORBIOTIN IS ACCELERATED BY SEVERAL PEROXISOME PROLIFERATORS AND STEROID-HORMONES IN RATS

      The Journal of nutrition
    58. FROYLAND L; MADSEN L; VAAGENES H; TOTLAND GK; AUWERX J; KRYVI H; STAELS B; BERGE RK
      MITOCHONDRION IS THE PRINCIPAL TARGET FOR NUTRITIONAL AND PHARMACOLOGICAL CONTROL OF TRIGLYCERIDE-METABOLISM

      Journal of lipid research
    59. HAWKE RL; CHAPMAN JM; WINEGAR DA; SALISBURY JA; WELCH RM; BROWN A; FRANZMANN KW; SIGEL C
      POTENT HYPOCHOLESTEROLEMIC ACTIVITY OF NOVEL UREIDO PHENOXYISOBUTYRATES CORRELATES WITH THEIR INTRINSIC FIBRATE POTENCY AND NOT WITH THEIR ACAT INHIBITORY ACTIVITY

      Journal of lipid research
    60. SOLIMAN MS; CUNNINGHAM ML; MORROW JD; ROBERTS J; BADR MZ
      EVIDENCE AGAINST PEROXISOME PROLIFERATION-INDUCED HEPATIC OXIDATIVE DAMAGE - LEVELS OF ESTERIFIED ISOPROSTANES IN LIVERS OF MICE FED A DIETCONTAINING 4-CHLORO-6-(2,3-XYLIDINO)-2-PYRIMIDINYLTHIO]ACETIC ACID (WY-14,643)

      Biochemical pharmacology
    61. MYERS KA; LAMBE KG; ALDRIDGE TC; MACDONALD N; TUGWOOD JD
      AMINO-ACID-RESIDUES IN BOTH THE DNA-BINDING AND LIGAND-BINDING DOMAINS INFLUENCE TRANSCRIPTIONAL ACTIVITY OF THE HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA

      Biochemical and biophysical research communications
    62. INOUE I; NOJI S; SHEN MZ; TAKAHASHI K; KATAYAMA S
      THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA (PPAR-ALPHA) REGULATES THE PLASMA THIOBARBITURIC ACID-REACTIVE SUBSTANCE (TBARS) LEVEL

      Biochemical and biophysical research communications
    63. RUYTER B; ANDERSEN O; DEHLI A; FARRANTS AKO; GJOEN T; THOMASSEN MS
      PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS IN ATLANTIC SALMON (SALMO-SALAR) - EFFECTS ON PPAR TRANSCRIPTION AND ACYL-COA OXIDASE ACTIVITY IN HEPATOCYTES BY PEROXISOME PROLIFERATORS AND FATTY-ACIDS

      Biochimica et biophysica acta, L. Lipids and lipid metabolism
    64. BOJES HK; THURMAN RG
      POTENT PEROXISOME PROLIFERATORS INHIBIT BETA-OXIDATION IN THE ISOLATED-PERFUSED RAT-LIVER

      Toxicology and applied pharmacology
    65. METELITSA VI; KOKURINA EV; BOCHKARRA EV; MARTSEVICH SY; DUDA SG; FILATOVA NP; RUMYANTSEV DO; BLAGODATSKIKH SV
      PROPHYLACTIC (PREVENTIVE) PHARMACOLOGY IN CARDIOLOGY - MODERN STATE

      Kardiologia
    66. SCHOONJANS K; STAELS B; AUWERX J
      ROLE OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) IN MEDIATING THE EFFECTS OF FIBRATES AND FATTY-ACIDS ON GENE-EXPRESSION

      Journal of lipid research
    67. SCHAD A; FAHIMI HD; VOLKL A; BAUMGART E
      NONRADIOACTIVE IN-SITU HYBRIDIZATION FOR DETECTION OF MESSENGER-RNAS ENCODING FOR PEROXISOMAL PROTEINS - HETEROGENEOUS HEPATIC LOBULAR DISTRIBUTION AFTER TREATMENT WITH A SINGLE-DOSE OF BEZAFIBRATE

      The Journal of histochemistry and cytochemistry
    68. STAELS B; VANTOL A; FRUCHART JC; AUWERX J
      EFFECTS OF HYPOLIPIDEMIC DRUGS ON THE EXPRESSION OF GENES INVOLVED INHIGH-DENSITY-LIPOPROTEIN METABOLISM IN THE RAT

      Israel journal of medical sciences
    69. GARBERG P; THULLBERG M
      DECREASED GLUTATHIONE-PEROXIDASE ACTIVITY IN MICE IN RESPONSE TO NAFENOPIN IS CAUSED BY CHANGES IN SELENIUM METABOLISM

      Chemico-biological interactions
    70. PINEAU T; HUDGINS WR; LIU L; CHEN LC; SHER T; GONZALEZ FJ; SAMID D
      ACTIVATION OF A HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR BY THE ANTITUMOR AGENT PHENYLACETATE AND ITS ANALOGS

      Biochemical pharmacology
    71. GILL JH; MOLLOY CA; SHOESMITH KJ; BAYLY AC; ROBERTS RA
      THE RODENT NONGENOTOXIC HEPATOCARCINOGEN NAFENOPIN AND EGF ALTER THE MITOSIS APOPTOSIS BALANCE PROMOTING HEPATOMA-CELL CLONAL GROWTH

      Cell death and differentiation
    72. HUANG Q; YELDANDI AV; ALVARES K; IDE H; REDDY JK; RAO MS
      LOCALIZATION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR IN MOUSE AND RAT-TISSUES AND DEMONSTRATION OF ITS NUCLEAR TRANSLOCATION IN TRANSFECTED CV-1 CELLS

      International journal of oncology
    73. ARNAIZ SL; TRAVACIO M; LLESUY S; BOVERIS A
      HYDROGEN-PEROXIDE METABOLISM DURING PEROXISOME PROLIFERATION BY FENOFIBRATE

      Biochimica et biophysica acta. Molecular basis of disease
    74. BOCOS C; OROZCO E; CASTRO W; QUACK G; HERRERA E
      EFFECT OF ETOFIBRATE ON BILE PRODUCTION IN THE NORMOLIPIDEMIC RAT

      General pharmacology
    75. JAMES NH; ASHBY J; ROBERTS RA
      ENHANCED HEPATOCYTE COLONY GROWTH IN SOFT AGAR AFTER IN-VIVO TREATMENT WITH A GENOTOXIC CARCINOGEN - A POTENTIAL ASSAY FOR HEPATOCARCINOGENS

      Cancer letters
    76. CORNUCHAGNON MC; DUPONT H; EDGAR A
      FENOFIBRATE - METABOLISM AND SPECIES-DIFFERENCES FOR PEROXISOME PROLIFERATION IN CULTURED-HEPATOCYTES

      Fundamental and applied toxicology
    77. ESPANDIARI P; THOMAS VA; GLAUERT HP; OBRIEN M; NOONAN D; ROBERTSON LW
      THE HERBICIDE DICAMBA (2-METHOXY-3,6-DICHLOROBENZOIC ACID) IS A PEROXISOME PROLIFERATOR IN RATS

      Fundamental and applied toxicology
    78. SCOTTO C; KELLER JM; SCHOHN H; DAUCA M
      COMPARATIVE EFFECTS OF CLOFIBRATE ON PEROXISOMAL ENZYMES OF HUMAN (HEP EBNA2) AND RAT (FAO) HEPATOMA-CELL LINES

      European journal of cell biology
    79. NISHIMURA S; YOKOYAMA Y; NAKANO H; SATOH K; KANO H; SATO K; TSUCHIDA S
      DECREASED EXPRESSION OF GLUTATHIONE S-TRANSFERASES AND INCREASED FATTY CHANGE IN PEROXISOMAL ENZYME-NEGATIVE FOCI INDUCED BY CLOFIBRATE IN RAT LIVERS

      Carcinogenesis
    80. GALLAGHER EP; BUETLER TM; STAPLETON PL; WANG CH; STAHL DL; EATON DL
      THE EFFECTS OF DIQUAT AND CIPROFIBRATE ON MESSENGER-RNA EXPRESSION AND CATALYTIC ACTIVITIES OF HEPATIC XENOBIOTIC-METABOLIZING AND ANTIOXIDANT ENZYMES IN RAT-LIVER

      Toxicology and applied pharmacology
    81. VUDAC N; SCHOOJANS K; KOSYKH V; DALLONGEVILLE J; FRUCHART JC; STAELS B; AUWERX J
      FIBRATES INCREASE HUMAN APOLIPOPROTEIN A-II EXPRESSION THROUGH ACTIVATION OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR

      The Journal of clinical investigation
    82. STAELS B; VUDAC N; KOSYKH VA; SALADIN R; FRUCHART JC; DALLONGEVILLE J; AUWERX J
      FIBRATES DOWN-REGULATE APOLIPOPROTEIN C-III EXPRESSION INDEPENDENT OFINDUCTION OF PEROXISOMAL ACYL-COENZYME-A OXIDASE - A POTENTIAL MECHANISM FOR THE HYPOLIPIDEMIC ACTION OF FIBRATES

      The Journal of clinical investigation
    83. ASIEDU DK; DEMOZ A; SKORVE J; GRAV HJ; BERGE RK
      ACUTE MODULATION OF RAT HEPATIC LIPID-METABOLISM BY SULFUR-SUBSTITUTED FATTY-ACID ANALOGS

      Biochemical pharmacology
    84. FOXWORTHY PS; EACHO PI
      CULTURED-HEPATOCYTES FOR STUDIES OF PEROXISOME PROLIFERATION - METHODS AND APPLICATIONS

      Journal of pharmacological and toxicological methods
    85. OHUE M; MAKITA T
      EFFECTS OF ORAL-ADMINISTRATION OF BEZAFIBRATE ON PEROXISOMES AND CARNITINE ACETYLTRANSFERASE IN RAT HEPATOCYTES

      Journal of veterinary medical science
    86. AHMAD D; CALDWELL J
      LACK OF STEREOSELECTIVITY OF THE PEROXISOME PROLIFERATION INDUCED BY 2-PHENYLPROPIONIC ACID - EVIDENCE AGAINST A ROLE FOR LIPID DISTURBANCEIN PEROXISOME PROLIFERATION

      Chirality
    87. MENNES WC; WORTELBOER HM; HASSING GAM; VANSANDWIJK K; TIMMERMAN A; SCHMID BP; JAHN U; BLAAUBOER BJ
      EFFECTS OF CLOFIBRIC AND BECLOBRIC ACID IN RAT AND MONKEY HEPATOCYTE PRIMARY CULTURE - INFLUENCE ON PEROXISOMAL AND MITOCHONDRIAL BETA-OXIDATION AND THE ACTIVITY OF CATALASE, GLUTATHIONE-S-TRANSFERASE AND GLUTATHIONE-PEROXIDASE

      Archives of toxicology
    88. KAWASHIMA Y; SUZUKI S; KOZUKA H; SATO M; SUZUKI Y
      EFFECTS OF PROLONGED ADMINISTRATION OF PERFLUOROOCTANOIC ACID ON HEPATIC ACTIVITIES OF ENZYMES WHICH DETOXIFY PEROXIDE AND XENOBIOTIC IN THE RAT

      Toxicology
    89. GRAHAM MJ; WILSON SA; WINHAM MA; SPENCER AJ; REES JA; OLD SL; BONNER FW
      LACK OF PEROXISOME PROLIFERATION IN MARMOSET LIVER FOLLOWING TREATMENT WITH CIPROFIBRATE FOR 3 YEARS

      Fundamental and applied toxicology
    90. INOUE I; TAKAHASHI K; KATAYAMA S; AKABANE S; NEGISHI K; SUZUKI M; ISHII J; KAWAZU S
      IMPROVEMENT OF GLUCOSE-TOLERANCE BY BEZAFIBRATE IN NONOBESE PATIENTS WITH HYPERLIPIDEMIA AND IMPAIRED GLUCOSE-TOLERANCE

      Diabetes research and clinical practice
    91. DHAUNSI GS; SINGH I; ORAK JK; SINGH AK
      ANTIOXIDANT ENZYMES IN CIPROFIBRATE-INDUCED OXIDATIVE STRESS

      Carcinogenesis
    92. RAO MS; IDE H; YELDANDI AV; KUMAR S; REDDY JK
      EXPRESSION OF PEROXISOMAL ENOYL-COA HYDRATASE 3-HYDROXYACYL-COA DEHYDROGENASE ENZYME AND ITS MESSENGER-RNA IN PEROXISOME PROLIFERATOR-INDUCED LIVER-TUMORS

      Carcinogenesis
    93. MANAUTOU JE; HOIVIK DJ; TVEIT A; HART SGE; KHAIRALLAH EA; COHEN SD
      CLOFIBRATE PRETREATMENT DIMINISHES ACETAMINOPHENS SELECTIVE COVALENT BINDING AND HEPATOTOXICITY

      Toxicology and applied pharmacology
    94. RIVERO A; MONREAL JI; GIL MJ
      PEROXISOME ENZYME MODIFICATION AND OXIDATIVE STRESS IN RAT BY HYPOLIPIDEMIC AND ANTIINFLAMMATORY DRUGS

      Revista Espanola de Fisiologia
    95. SHAND JH; WEST DW
      THE EFFECTS OF CLOFIBRATE AND BEZAFIBRATE ON CHOLESTEROL-METABOLISM IN THE LIVER OF THE MALE-RAT

      Lipids
    96. CHANDOGA J; HAMPL L; TURECKY L; ROJEKOVA I; UHLIKOVA E; HOCMAN G
      CETABEN IS AN EXCEPTIONAL TYPE OF PEROXISOME PROLIFERATOR

      International Journal of Biochemistry
    97. POZDEEVA EV; PETRICHENKO IE; AKHMEDZHANOV NM; ZHIDKO NI; SHAKHOV YA
      EFFECT OF LONG-TERM LOVASTATIN TREATMENT ON THE NUMBER OF GLUCOCORTICOID RECEPTORS IN PERIPHERAL-BLOOD LYMPHOCYTES

      Bulletin of experimental biology and medicine
    98. ALEGRET M; FERRANDO R; VAZQUEZ M; ADZET T; MERLOS M; LAGUNA JC
      RELATIONSHIP BETWEEN PLASMA-LIPIDS AND PALMITOYL-COA HYDROLASE AND SYNTHETASE ACTIVITIES WITH PEROXISOMAL PROLIFERATION IN RATS TREATED WITH FIBRATES

      British Journal of Pharmacology
    99. FOLIOT A; BEAUNE P
      EFFECTS OF MICROSOMAL-ENZYME INDUCERS ON GLUTATHIONE-S-TRANSFERASE ISOENZYMES IN LIVERS OF RATS AND HAMSTERS

      Biochemical pharmacology
    100. SOHLENIUS AK; ANDERSSON K; BERGSTRAND A; SPYDEVOLD O; DEPIERRE JW
      EFFECTS OF PERFLUOROOCTANOIC ACID - A POTENT PEROXISOME PROLIFERATOR IN RAT - ON MORRIS HEPATOMA-7800C1 CELLS, A RAT-CELL LINE

      Biochimica et biophysica acta, L. Lipids and lipid metabolism


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 13:15:53